Payment overview · 2025
General Payments
$17.35
1 reported records · 1 companies
Healthcare provider profile · identity verified
Mark L Lipham, MD
Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease · CARROLLTON, GA · NPI 1437192697
Verified facts
What the public records show
CMS Open Payments records show Mark L Lipham, MD received $17.35 in general payments during 2025 across 1 reported records.
AstraZeneca Pharmaceuticals LP accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 31 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 19 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $17.35 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $17.35 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $17.35 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 28 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
31 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
28 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
19 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 1410 | 151 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1381 | 160 |
| Omeprazole | Omeprazole | 1124 | 140 |
| Eliquis | Apixaban | 1072 | 109 |
| Gabapentin | Gabapentin | 1007 | 121 |
| Levothyroxine Sodium | Levothyroxine Sodium | 955 | 122 |
| Lisinopril | Lisinopril | 831 | 75 |
| Furosemide | Furosemide | 820 | 117 |
| Tamsulosin Hcl | Tamsulosin Hcl | 778 | 91 |
| Pravastatin Sodium | Pravastatin Sodium | 721 | 67 |
| Trazodone Hcl | Trazodone Hcl | 696 | 73 |
| Potassium Chloride | Potassium Chloride | 670 | 104 |
| Metoprolol Succinate | Metoprolol Succinate | 612 | 89 |
| Mirtazapine | Mirtazapine | 610 | 60 |
| Metoprolol Tartrate | Metoprolol Tartrate | 575 | 76 |
| Pantoprazole Sodium | Pantoprazole Sodium | 571 | 83 |
| Donepezil Hcl | Donepezil Hcl | 561 | 61 |
| Famotidine | Famotidine | 531 | 40 |
| Memantine Hcl | Memantine Hcl | 526 | 51 |
| Metformin Hcl | Metformin Hcl | 513 | 76 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 507 | 82 |
| Clopidogrel | Clopidogrel Bisulfate | 503 | 68 |
| Escitalopram Oxalate | Escitalopram Oxalate | 499 | 56 |
| Levetiracetam | Levetiracetam | 450 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 443 | 54 |
| Sertraline Hcl | Sertraline Hcl | 411 | 57 |
| Carvedilol | Carvedilol | 404 | 55 |
| Quetiapine Fumarate | Quetiapine Fumarate | 390 | 44 |
| Divalproex Sodium | Divalproex Sodium | 377 | 39 |
| Buspirone Hcl | Buspirone Hcl | 362 | 38 |
| Meloxicam | Meloxicam | 348 | 47 |
| Valsartan | Valsartan | 310 | 41 |
| Tramadol Hcl | Tramadol Hcl | 308 | 72 |
| Lorazepam | Lorazepam | 297 | 56 |
| Montelukast Sodium | Montelukast Sodium | 252 | 26 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 250 | 15 |
| Risperidone | Risperidone | 249 | 24 |
| Finasteride | Finasteride | 248 | 21 |
| Paroxetine Hcl | Paroxetine Hcl | 247 | 25 |
| Fluoxetine Hcl | Fluoxetine Hcl | 240 | 17 |
| Spironolactone | Spironolactone | 239 | 25 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 234 | 36 |
| Sucralfate | Sucralfate | 233 | 27 |
| Baclofen | Baclofen | 232 | 19 |
| Alprazolam | Alprazolam | 230 | 35 |
| Citalopram Hbr | Citalopram Hydrobromide | 224 | 28 |
| Clonidine Hcl | Clonidine Hcl | 224 | 20 |
| Ondansetron Hcl | Ondansetron Hcl | 215 | 98 |
| Fluticasone Propionate | Fluticasone Propionate | 210 | 59 |
| Aripiprazole | Aripiprazole | 204 | 14 |
| Losartan Potassium | Losartan Potassium | 194 | 42 |
| Pregabalin | Pregabalin | 194 | 42 |
| Januvia | Sitagliptin Phosphate | 190 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 180 | 61 |
| Simvastatin | Simvastatin | 179 | 38 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 168 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 167 | 23 |
| Oxcarbazepine | Oxcarbazepine | 164 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 163 | 30 |
| Allopurinol | Allopurinol | 161 | 33 |
| Midodrine Hcl | Midodrine Hcl | 158 | 28 |
| Jardiance | Empagliflozin | 155 | 14 |
| Atenolol | Atenolol | 147 | 21 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 147 | 14 |
| Amiodarone Hcl | Amiodarone Hcl | 146 | 13 |
| Temazepam | Temazepam | 146 | 26 |
| Prednisone | Prednisone | 141 | 43 |
| Diltiazem 24hr Er | Diltiazem Hcl | 140 | suppressed |
| Belsomra | Suvorexant | 138 | 17 |
| Clonazepam | Clonazepam | 135 | 23 |
| Sevelamer Carbonate | Sevelamer Carbonate | 135 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 133 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 130 | 19 |
| Latanoprost | Latanoprost | 126 | 30 |
| Ropinirole Hcl | Ropinirole Hcl | 122 | suppressed |
| Myrbetriq | Mirabegron | 121 | 13 |
| Nifedipine Er | Nifedipine | 120 | 17 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 119 | 53 |
| Fenofibrate | Fenofibrate Nanocrystallized | 113 | 11 |
| Olanzapine | Olanzapine | 112 | 13 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 110 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 108 | 27 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 106 | 17 |
| Glipizide | Glipizide | 104 | suppressed |
| Humalog | Insulin Lispro | 101 | 17 |
| Entresto | Sacubitril/Valsartan | 97 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 93 | 14 |
| Glimepiride | Glimepiride | 92 | 23 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 91 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 90 | 22 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 90 | 59 |
| Ezetimibe | Ezetimibe | 89 | 19 |
| Levofloxacin | Levofloxacin | 88 | 64 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 85 | 15 |
| Flecainide Acetate | Flecainide Acetate | 82 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 79 | 23 |
| Terazosin Hcl | Terazosin Hcl | 77 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 77 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 76 | 14 |
| Topiramate | Topiramate | 75 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 73 | 14 |
| Diltiazem Hcl | Diltiazem Hcl | 70 | suppressed |
| Lamotrigine | Lamotrigine | 70 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 70 | suppressed |
| Cephalexin | Cephalexin | 68 | 49 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 67 | 45 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 67 | suppressed |
| Methotrexate | Methotrexate Sodium | 67 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 63 | 19 |
| Nystatin | Nystatin | 63 | 31 |
| Ipratropium Bromide | Ipratropium Bromide | 59 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 59 | 22 |
| Azithromycin | Azithromycin | 58 | 36 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 58 | 13 |
| Promethazine Hcl | Promethazine Hcl | 58 | 20 |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 58 | suppressed |
| Gemtesa | Vibegron | 57 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 56 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 56 | 39 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 56 | 14 |
| Warfarin Sodium | Warfarin Sodium | 55 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 54 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 53 | suppressed |
| Telmisartan | Telmisartan | 53 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 53 | 27 |
| Valproic Acid | Valproic Acid | 53 | suppressed |
| Bupropion Xl | Bupropion Hcl | 52 | 14 |
| Meclizine Hcl | Meclizine Hcl | 52 | 23 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 52 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 52 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 51 | suppressed |
| Trulicity | Dulaglutide | 50 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 50 | suppressed |
| Ibuprofen | Ibuprofen | 49 | 12 |
| Fluconazole | Fluconazole | 48 | 33 |
| Amoxicillin | Amoxicillin | 47 | 36 |
| Lovastatin | Lovastatin | 47 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 46 | 13 |
| Dayvigo | Lemborexant | 46 | suppressed |
| Lactulose | Lactulose | 46 | suppressed |
| Mounjaro | Tirzepatide | 46 | suppressed |
| Celecoxib | Celecoxib | 45 | 13 |
| Methocarbamol | Methocarbamol | 45 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 44 | 19 |
| Insulin Aspart Flexpen | Insulin Aspart | 44 | 27 |
| Novolog | Insulin Aspart | 44 | 13 |
| Metoclopramide Hcl | Metoclopramide Hcl | 42 | suppressed |
| Diazepam | Diazepam | 41 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 41 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 41 | suppressed |
| Metolazone | Metolazone | 40 | suppressed |
| Darifenacin Er | Darifenacin Hydrobromide | 39 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 39 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 39 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 39 | 14 |
| Fiasp | Insulin Aspart (Niacinamide) | 38 | suppressed |
| Linzess | Linaclotide | 38 | 12 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 37 | suppressed |
| Glucagon Emergency Kit | Glucagon | 37 | suppressed |
| Paroxetine Er | Paroxetine Hcl | 37 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 36 | 11 |
| Synthroid | Levothyroxine Sodium | 36 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 35 | suppressed |
| Ondansetron Odt | Ondansetron | 35 | 20 |
| Primidone | Primidone | 35 | suppressed |
| Torsemide | Torsemide | 35 | 14 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 35 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 34 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 33 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 33 | suppressed |
| Brilinta | Ticagrelor | 31 | suppressed |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 31 | suppressed |
| Xifaxan | Rifaximin | 31 | suppressed |
| Calcium Acetate | Calcium Acetate | 30 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 30 | suppressed |
| Fentanyl | Fentanyl | 30 | suppressed |
| Levemir | Insulin Detemir | 30 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 30 | 15 |
| Ventolin Hfa | Albuterol Sulfate | 30 | suppressed |
| Xarelto | Rivaroxaban | 30 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 29 | 16 |
| Doxepin Hcl | Doxepin Hcl | 29 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 29 | suppressed |
| Carisoprodol | Carisoprodol | 28 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 28 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 28 | 21 |
| Farxiga | Dapagliflozin Propanediol | 28 | suppressed |
| Rexulti | Brexpiprazole | 28 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 27 | 13 |
| Novolog Flexpen | Insulin Aspart | 27 | suppressed |
| Phenytoin | Phenytoin | 27 | suppressed |
| Timolol Maleate | Timolol Maleate | 27 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 26 | suppressed |
| Lacosamide | Lacosamide | 26 | suppressed |
| Nitroglycerin | Nitroglycerin | 26 | 21 |
| Theophylline Er | Theophylline Anhydrous | 25 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 24 | suppressed |
| Constulose | Lactulose | 24 | suppressed |
| Digoxin | Digoxin | 24 | suppressed |
| Ozempic | Semaglutide | 24 | suppressed |
| Lubiprostone | Lubiprostone | 23 | suppressed |
| Austedo | Deutetrabenazine | 22 | suppressed |
| Fenofibrate | Fenofibrate | 22 | suppressed |
| Haloperidol | Haloperidol | 22 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 22 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 22 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 22 | suppressed |
| Modafinil | Modafinil | 22 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 22 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 21 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 21 | 19 |
| Loperamide | Loperamide Hcl | 21 | 12 |
| Repaglinide | Repaglinide | 21 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 21 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 20 | 12 |
| Bumetanide | Bumetanide | 19 | suppressed |
| Eszopiclone | Eszopiclone | 19 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 19 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 19 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 18 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 18 | suppressed |
| Estradiol | Estradiol | 18 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 18 | suppressed |
| Hydrocortisone | Hydrocortisone | 18 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 18 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Verapamil Er | Verapamil Hcl | 18 | suppressed |
| Enulose | Lactulose | 17 | suppressed |
| Folic Acid | Folic Acid | 17 | suppressed |
| Levemir Flexpen | Insulin Detemir | 17 | suppressed |
| Premarin | Estrogens, Conjugated | 17 | suppressed |
| Anastrozole | Anastrozole | 16 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 16 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 16 | suppressed |
| Ramipril | Ramipril | 16 | suppressed |
| Ranolazine Er | Ranolazine | 16 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 16 | suppressed |
| Paroxetine Cr | Paroxetine Hcl | 15 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 15 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 15 | 14 |
| Ziprasidone Hcl | Ziprasidone Hcl | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 14 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 14 | suppressed |
| Mupirocin | Mupirocin | 14 | 11 |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 14 | suppressed |
| Restasis | Cyclosporine | 14 | suppressed |
| Butalb-Acetaminoph-Caff-Codein | Butalbit/Acetamin/Caff/Codeine | 13 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Jantoven | Warfarin Sodium | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Admelog | Insulin Lispro | 11 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 11 | suppressed |
| Klor-Con 10 | Potassium Chloride | 11 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 11 | suppressed |
| Naproxen | Naproxen | 11 | suppressed |
| Pentoxifylline | Pentoxifylline | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
| Rivastigmine | Rivastigmine | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.35 · 1 records | AstraZeneca Pharmaceuticals LP | FARXIGA | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Farxiga play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error